Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Name: Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Published: 2011
License: Public Domain

Celgene · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

carcinoma glioblastoma lymphoma multiple-myeloma

multiple myeloma, lymphoma, large b-cell, diffuse, pleiotropic pathway modifier, glioblastoma, lymphoma, primary central nervous system lymphoma, neoplasm, malignancy, carcinoma, dna-pk inhibitor, advanced solid tumors, glioblastoma multiforme

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 845610
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.